ETF Holdings Breakdown of AMRX

Stock NameAmneal Pharmaceuticals, Inc. Class A Common Stock
TickerAMRX(USD) NYSE
TYPECommon Stock
CountryUSA
ISINUS03168L1052
LEI549300VV176ZO5WQHZ61

News associated with AMRX

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Shares Bought by Principal Financial Group Inc.
Principal Financial Group Inc. grew its holdings in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Free Report) by 9.3% in the 4th quarter, HoldingsChannel.com reports. The firm owned 96,835 shares of the company’s stock after purchasing an additional 8,213 shares during the quarter. Principal Financial Group Inc.’s holdings in Amneal Pharmaceuticals were worth $767,000 as […] - 2025-03-07 08:21:06
Analysts Set Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Target Price at $10.60
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) has been given a consensus recommendation of “Buy” by the five research firms that are currently covering the stock, Marketbeat Ratings reports. Five research analysts have rated the stock with a buy recommendation. The average 1-year price target among brokerages that have issued a report on the […] - 2025-03-05 06:55:12
Rhumbline Advisers Acquires 7,875 Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)
Rhumbline Advisers boosted its position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Free Report) by 3.5% in the fourth quarter, HoldingsChannel.com reports. The firm owned 232,264 shares of the company’s stock after acquiring an additional 7,875 shares during the period. Rhumbline Advisers’ holdings in Amneal Pharmaceuticals were worth $1,840,000 as of its most recent SEC filing. […] - 2025-03-04 08:12:48
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Shares Purchased by Y Intercept Hong Kong Ltd
Y Intercept Hong Kong Ltd lifted its holdings in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Free Report) by 55.3% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 58,111 shares of the company’s stock after purchasing an additional 20,686 shares during the period. Y Intercept Hong Kong Ltd’s […] - 2025-03-03 08:28:58
Amneal Pharmaceuticals (NASDAQ:AMRX) Rating Increased to Overweight at JPMorgan Chase & Co.
Amneal Pharmaceuticals (NASDAQ:AMRX – Get Free Report) was upgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating in a note issued to investors on Monday, Marketbeat Ratings reports. The firm presently has a $12.00 price objective on the stock, up from their previous price objective of $9.00. JPMorgan […] - 2025-02-26 07:01:03
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Short Interest Down 18.0% in January
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) saw a significant decline in short interest in January. As of January 31st, there was short interest totalling 2,420,000 shares, a decline of 18.0% from the January 15th total of 2,950,000 shares. Currently, 1.9% of the shares of the company are sold short. Based on an average […] - 2025-02-17 08:44:56
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Receives $10.00 Average PT from Brokerages
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the five brokerages that are currently covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average 1 year target […] - 2025-02-06 06:06:55
Empirical Financial Services LLC d.b.a. Empirical Wealth Management Acquires 5,523 Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)
Empirical Financial Services LLC d.b.a. Empirical Wealth Management increased its holdings in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Free Report) by 13.6% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 46,240 shares of the company’s stock after purchasing an additional 5,523 shares […] - 2025-01-30 08:57:13

AMRX institutional holdings

The following institutional investment holdings of AMRX have been identified

Date ETF ISIN/Name Num Shares Book value
2025-03-12 IE00BF4RFH31 (Ishares III PLC - Ishares Msci World Small Cap UCITS ETF) 72,693 -0.5%USD 645,514 0.0%
2025-03-12 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 14,822 -10.1%USD 131,619 -9.6%
2025-03-12 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 152,911USD 1,357,850 0.5%
2025-03-12 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 152,911USD 1,357,850 0.5%
2025-03-12 IE000T9EOCL3 (iS Wor ESG En Acc) 519USD 4,609 0.5%
Total =393,856 USD 3,497,442
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.